Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Philip

Showing results (371-380 of 520) with videos related to

Pageof 52
Sort By:
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|December 3, 2019
Transrectal high-intensity focused ultrasound (HIFU) for management of rectosigmoid deep infiltrating endometriosis: results of Phase-I clinical trialC-A Philip, S Warembourg, M Dairien, et al.
Drug and Alcohol Dependence|December 31, 1991
Potent substituted-3 beta-phenyltropane analogs of cocaine have cocaine-like discriminative stimulus effectsR L Balster, F I Carroll, J H Graham, et al.
Medical Oncology (Northwood, London, England)|October 24, 2009
Clinicopathological analysis of primary epithelial appendiceal neoplasmsSachin Gupta, Venkata Parsa, Volkan Adsay, et al.
Cancer|July 13, 2012
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trialsTodd M Bauer, Bassel F El-Rayes, Xiaobai Li, et al.
Cancer Metastasis Reviews|September 9, 2021
Targeting KRAS in pancreatic cancer: new drugs on the horizonSahar F Bannoura, Md Hafiz Uddin, Misako Nagasaka, et al.
Cancer|August 16, 2001
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinomaP A Philip, M M Zalupski, V K Vaitkevicius, et al.
Molecular Cancer Therapeutics|January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal AdenocarcinomaAmro Aboukameel, Irfana Muqbil, William Senapedis, et al.
Annals of the New York Academy of Sciences|June 28, 1992
High potency cocaine analogs: neurochemical, imaging, and behavioral studiesJ W Boja, E J Cline, F I Carroll, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancerEdgar Ben-Josef, Anthony F Shields, Ulka Vaishampayan, et al.
American Journal of Translational Research|September 10, 2011
Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanismAsfar S Azmi, Shadan Ali, Sanjeev Banerjee, et al.
Pageof 52

Showing results (371-380 of 520) with videos related to

Sort By:
Pageof 52
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|December 3, 2019
Transrectal high-intensity focused ultrasound (HIFU) for management of rectosigmoid deep infiltrating endometriosis: results of Phase-I clinical trialC-A Philip, S Warembourg, M Dairien, et al.
Drug and Alcohol Dependence|December 31, 1991
Potent substituted-3 beta-phenyltropane analogs of cocaine have cocaine-like discriminative stimulus effectsR L Balster, F I Carroll, J H Graham, et al.
Medical Oncology (Northwood, London, England)|October 24, 2009
Clinicopathological analysis of primary epithelial appendiceal neoplasmsSachin Gupta, Venkata Parsa, Volkan Adsay, et al.
Cancer|July 13, 2012
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trialsTodd M Bauer, Bassel F El-Rayes, Xiaobai Li, et al.
Cancer Metastasis Reviews|September 9, 2021
Targeting KRAS in pancreatic cancer: new drugs on the horizonSahar F Bannoura, Md Hafiz Uddin, Misako Nagasaka, et al.
Cancer|August 16, 2001
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinomaP A Philip, M M Zalupski, V K Vaitkevicius, et al.
Molecular Cancer Therapeutics|January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal AdenocarcinomaAmro Aboukameel, Irfana Muqbil, William Senapedis, et al.
Annals of the New York Academy of Sciences|June 28, 1992
High potency cocaine analogs: neurochemical, imaging, and behavioral studiesJ W Boja, E J Cline, F I Carroll, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancerEdgar Ben-Josef, Anthony F Shields, Ulka Vaishampayan, et al.
American Journal of Translational Research|September 10, 2011
Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanismAsfar S Azmi, Shadan Ali, Sanjeev Banerjee, et al.
Pageof 52